- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Alfresa's net sales FY 2017, by segment
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Alfresa's net sales FY 2017, by segment
Net sales of Alfresa Holdings Corporation in fiscal year 2017, by business segment (in billion Japanese yen)
by Statista Research Department,
last edited
Jul 4, 2019
This statistic depicts the net sales of Alfresa Holdings Corporation in fiscal year 2017, sorted by business segment. In the fiscal year ended March 31, 2018, the ethical pharmaceutical wholesaling business accounted for the largest share of the company's net sales with almost 2.3 trillion Japanese yen. In the same period, the medical-related business recorded net sales valued at around 34 billion yen.
Net sales of Alfresa Holdings Corporation in fiscal year 2017, by business segment (in billion Japanese yen)
| Net sales in billion Japanese yen | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| Net sales in billion Japanese yen | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
Jul 4, 2019
This statistic depicts the net sales of Alfresa Holdings Corporation in fiscal year 2017, sorted by business segment. In the fiscal year ended March 31, 2018, the ethical pharmaceutical wholesaling business accounted for the largest share of the company's net sales with almost 2.3 trillion Japanese yen. In the same period, the medical-related business recorded net sales valued at around 34 billion yen.
- Show sources information
- Show publisher information
- Release date
- October 2018
- Region
- Japan
- Survey time period
- fiscal year 2017; the company's fiscal year starts April 1 of the stated year and ends March 31 of the following year
- Special properties
- consolidated figures
- Supplementary notes
-
Figures include intersegment sales.
1 Japanese yen equals 0.0092 U.S. dollars or 0.0082 euros as of July 2019.
Source
- Show sources information
- Show publisher information
- Release date
- October 2018
More information
- Region
- Japan
- Survey time period
- fiscal year 2017; the company's fiscal year starts April 1 of the stated year and ends March 31 of the following year
- Special properties
- consolidated figures
- Supplementary notes
-
Figures include intersegment sales.
1 Japanese yen equals 0.0092 U.S. dollars or 0.0082 euros as of July 2019.
Other statistics on the topic
+Pharmaceutical Products & Market
Leading 18 European pharmaceutical companies by retail sales 2015
+Pharmaceutical Products & Market
Turnover of leading European pharmaceutical markets 2017
Pharmaceutical Products & Market
Self-medication market sales in Europe in 2017, by country
+Pharmaceutical Products & Market
Turnover of pharmaceutical markets in Central and Eastern Europe 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Pharmaceutical industry in the Netherlands"
- Industry overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Number of drugstores in the Netherlands in 2017, by typeNumber of drugstores in the Netherlands 2017, by type
- Annual revenue of pharmaceutical care within the basic health insurance package from 2008 to 2018 (in million euros)Pharmaceutical revenue within basic health insurance in the Netherlands 2008-2018
- Most frequently used medicines among youth in the Netherlands in 2015* Most frequently used medicines among youth in the Netherlands 2015
- Leading medicines with the highest usage in the Netherlands in 2018 (in millions)Leading medicines with the highest usage in the Netherlands 2018
- Leading medicines with the highest expenditure in the Netherlands in 2018 (in million euros)*Medicines with the highest expenditure in the Netherlands 2018
- Leading prescribed medicines in the Netherlands in 2018, by total expenditure (in million euros)*Prescribed medicines in the Netherlands in 2018, by total expenditure
- Dispensed medicines
The most important statistics
- Number of dispensed diabetes medicines and goods in the Netherlands from 2013 to 2017*Dispensed diabetes medicines and goods in the Netherlands 2013-2017
- Number of dispensed asthma/COPD medicines in the Netherlands from 2013 to 2017*Dispensed asthma/COPD medicines in the Netherlands 2013-2017
- Number of dispensed analgesics in the Netherlands from 2013 to 2017*Dispensed analgesics in the Netherlands 2013-2017
- Number of dispensed antiepileptic medicines in the Netherlands from 2013 to 2017*Dispensed antiepileptic medicines in the Netherlands 2013-2017
- Number of dispensed antidepressants in the Netherlands from 2013 to 2017*Dispensed antidepressants in the Netherlands 2013-2017
- Total usage of dispensed diabetes medicines and goods in the Netherlands from 2013 to 2017*Usage of dispensed diabetes medicines and goods in the Netherlands 2013-2017
- Total usage of dispensed asthma/COPD medicines in the Netherlands from 2013 to 2017 (in 1,000s)Usage of dispensed asthma/COPD medicines in the Netherlands 2013-2017
- Total number of users of dispensed antiepileptic medicines in the Netherlands from 2013 to 2017*Usage of dispensed antiepileptic medicines in the Netherlands 2013-2017
- Self-care medication
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Annual revenue of self-care medicines in the Netherlands in 2017, by product segment (in million euros)*Revenue of self-care medicines in the Netherlands 2017, by product segment
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Percentage change on previous year of the revenue in self-care medicines in the Netherlands in 2017, by product segmentRevenue change in self-care medicines in the Netherlands 2017, by product segment
- Distribution of self-care medicines sales in the Netherlands in 2017, by purchase channel*Distribution self-care medicines sales in the Netherlands 2017, by purchase channel
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)Revenue of self-care medicines in supermarkets in the Netherlands 2017, by segment
- Pharmacies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2015
- Number of pharmacies in the Netherlands from 2012 to 2018*Number of pharmacies in the Netherlands 2012-2018
- Number of public pharmacies in the Netherlands from 2015 to 2018, by typeNumber of public pharmacies in the Netherlands 2015-2018, by type
- Average medicine costs and tariff revenues per pharmacy in the Netherlands from 2011 to 2018 (in 1,000 euros)Average medicine costs and tariff revenues per pharmacy in the Netherlands 2011-2018
- Average pharmacy costs per person under the Dutch Health Insurance Act (Zvw) from 2009 to 2016 (in euros)Pharmacy costs per person under the Dutch Health Insurance Act (Zvw) 2009-2016
- Average pharmacy costs per person under the Dutch Health Insurance Act (Zvw) from 2009 to 2016, by gender (in euros)Pharmacy costs per person under Dutch Health Insurance Act (Zvw) 2009-2016, by gender
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Studies
- Pharmaceutical industry in the Netherlands
- Follow the Dollar
- Antibiotic use in the United Kingdom (UK)
- Cardinal Health
- Pharmaceutical industry in the United Kingdom (UK)
- Pharmaceutical industry in Italy
- Pharmaceutical industry in Sweden
- Pharmaceutical industry in Denmark
- Pharmaceutical market in Sweden
- Pharmaceutical market in Norway
- Pharmaceutical industry in Norway
- Pharmaceutical trends in Europe
- Chart Pack - Biopharmaceuticals in Perspective (2019)
- Medtronic - 2019 Form 10-K
- CVS Health - 2018 Form 10-K
Statistics on "Pharmaceutical industry in the Netherlands"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Number of drugstores in the Netherlands in 2017, by type
- Annual revenue of pharmaceutical care within the basic health insurance package from 2008 to 2018 (in million euros)
- Most frequently used medicines among youth in the Netherlands in 2015*
- Leading medicines with the highest usage in the Netherlands in 2018 (in millions)
- Leading medicines with the highest expenditure in the Netherlands in 2018 (in million euros)*
- Leading prescribed medicines in the Netherlands in 2018, by total expenditure (in million euros)*
- Number of dispensed diabetes medicines and goods in the Netherlands from 2013 to 2017*
- Number of dispensed asthma/COPD medicines in the Netherlands from 2013 to 2017*
- Number of dispensed analgesics in the Netherlands from 2013 to 2017*
- Number of dispensed antiepileptic medicines in the Netherlands from 2013 to 2017*
- Number of dispensed antidepressants in the Netherlands from 2013 to 2017*
- Total usage of dispensed diabetes medicines and goods in the Netherlands from 2013 to 2017*
- Total usage of dispensed asthma/COPD medicines in the Netherlands from 2013 to 2017 (in 1,000s)
- Total number of users of dispensed antiepileptic medicines in the Netherlands from 2013 to 2017*
- Total usage of dispensed analgesics in the Netherlands from 2013 to 2017*
- Total usage of dispensed antidepressants in the Netherlands from 2013 to 2017*
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Annual revenue of self-care medicines in the Netherlands in 2017, by product segment (in million euros)*
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Percentage change on previous year of the revenue in self-care medicines in the Netherlands in 2017, by product segment
- Distribution of self-care medicines sales in the Netherlands in 2017, by purchase channel*
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)
- Number of pharmacies in the Netherlands from 2012 to 2018*
- Number of public pharmacies in the Netherlands from 2015 to 2018, by type
- Average medicine costs and tariff revenues per pharmacy in the Netherlands from 2011 to 2018 (in 1,000 euros)
- Average pharmacy costs per person under the Dutch Health Insurance Act (Zvw) from 2009 to 2016 (in euros)
- Average pharmacy costs per person under the Dutch Health Insurance Act (Zvw) from 2009 to 2016, by gender (in euros)
- Net sales of Alfresa Holdings Corporation from fiscal year 2013 to 2017 (in trillion Japanese yen)
- Net sales of Alfresa Holdings Corporation's ethical pharmaceuticals wholesaling business from fiscal year 2014 to 2018 (in trillion Japanese yen)
- Net sales of VECOL S.A. from 2016 to 2018, by business segment (in billion Colombian pesos)
- Net sales of Alfresa Holdings Corporation's self-medication products wholesaling business from fiscal year 2014 to 2018 (in billion Japanese yen)
- Net sales of Alfresa Holdings Corporation's manufacturing business from fiscal year 2014 to 2018 (in billion Japanese yen)
- Net sales of Alfresa Holdings Corporation's medical-related business from fiscal years 2015 to 2018 (in billion Japanese yen)
- Net sales of Taisho Pharmaceutical Holdings Co., Ltd. from fiscal year 2013 to 2017 (in billion Japanese yen)
- Net sales of Indian pharma companies from H1 2017 to H1 2019 (in billion Indian rupees)
- Net sales distribution of Otsuka Pharmaceutical Co., Ltd. in fiscal year 2018, by business segment*
- Net sales of Midsona from 2012 to 2018 (in million SEK)
- Net sales of VECOL S.A. from 2016 to 2018 (in billion Colombian pesos)
- Net sales of hospitals and healthcare services India between FY 2013 and FY 2017 (in billion Indian rupees)*
- Net sales change rate of Indian pharma industry from H1 2017 to H1 2019
- Net sales of top global biotechnology companies in 2017/2018 (in million U.S. dollars)
- Comparison of the top U.S. pharmaceutical manufacturer vs. the top U.S. pharmaceutical distributor as of 2018
- Net sales of Meiji Holdings Co., Ltd. from fiscal year 2013 to 2018 (in trillion Japanese yen)
- Net sales of Terumo Corporation in fiscal years 2012 to 2017 (in billion Japanese yen)
- Net sales of the pharmaceutical segment of Meiji Holdings Co., Ltd. from fiscal year 2013 to 2018 (in billion Japanese yen)
- Net sales of Midsona in 2018, by country (in million SEK)
- Net sales of Novo Nordisk from 2008 to 2018 (in million DKK)
- Operating income of Alfresa Holdings Corporation in fiscal year 2017, by business segment (in billion Japanese yen)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.